查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1463045

人類生長激素市場、佔有率、規模、趨勢、產業分析報告：依類型、給藥途徑、年齡、適應症、分銷管道、地區、細分市場預測，2024-2032 年

Human Growth Hormone Market Share, Size, Trends, Industry Analysis Report, By Type (Long-acting, Short-acting & Intermediate-acting); By Route of Administration; By Age; By Indication; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球人類生長激素市場規模預計將達到156.6億美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

人類生長激素 (HGH) 市場的範圍涵蓋了定義其範圍、應用和影響因素的各個維度。 該市場致力於 HGH 的治療用途，解決兒童和成人生長激素缺乏症等醫療狀況。 HGH 用於刺激內源性生長激素分泌不足的人的生長和發育。

市場的很大一部分專注於解決兒童生長障礙，包括由於生長激素缺乏而導致身材矮小等疾病。 HGH 療法是促進兒童線性生長的常見療法。 該市場也擴大到包括生長激素缺乏症的成年人，其中 HGH 用於治療 AGHD 等疾病。 這包括解決成年期間與生長激素缺乏相關的健康問題。 市場上也有越來越多的領域涉及抗衰老和健康應用。 HGH 有時也因其明顯的抗衰老作用而被使用，包括改善皮膚健康、能量水平和整體健康。

此外，HGH也用於治療肌肉無力和代謝紊亂。 市場正在解決 HGH 的治療用途，以減輕特定患者群體肌肉損失的影響並改善代謝功能。

生長激素缺乏症(GHD) 的高盛行率、由於與GHD 相關的嚴重風險而促使的治療需求不斷增加，以及對減少注射頻率的藥物的需求不斷增長，正在推動人類生長激素市場的發展，這是導致這一問題的主要因素。

腦下垂體功能不全病例數量的增加以及為提高患者治療依從性而開發更先進技術的市場等因素也促進了市場的成長。 產業參與者對研發活動的日益關注，再加上生長激素的強大管道，預計將在預測期內推動市場成長。

對適當治療的認識不斷提高，以及公共和私人組織在治療人類生長缺陷方面不斷採取的舉措，預計將有利於人類生長激素市場的擴張。 此外，新興國家受罕見疾病影響的患者數量不斷增加也將有助於市場發展。

人類生長激素市場報告亮點

由於長效人類生長激素的安全性和有效性，預計長效細分市場在預測期內將以最高複合年增長率擴張。

2023 年，由於疾病的高盛行率以及治療該疾病的新產品數量不斷增加，生長激素缺乏症領域佔了最大的市場佔有率。

2023年，由於就診醫院的病患數量不斷增加，醫院藥局部門佔了最大的市場佔有率。

由於特納氏症和生長激素缺乏症病例的增加，2023 年北美在人類生長激素市場中佔最大的收入佔有率。

市場參與者包括AnkeBio Co., Ltd.、Ascendis Pharma、Novo Nordisk、Pfizer、Eli Lilly、Sandoz International、Merck、Genentech等。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第四章全球人類生長激素市場洞察

  • 人類生長激素 - 產業概況
  • 人類生長激素市場動態
    • 推動者和機會
      • 生長激素缺乏症和其他疾病的盛行率增加
      • 研發活動增加
    • 抑制因素和課題
      • 副作用與安全性問題
  • 杵分析
  • 人類生長激素產業的趨勢
  • 新冠肺炎 (COVID-19) 影響分析

第 5 章世界市場（依類型）

  • 主要發現
  • 簡介
  • 長效
  • 短效與中效

第 6 章依管理途徑劃分的全球市場

  • 主要發現
  • 簡介
  • 口頭
  • 注射用

第 7 章依年齡劃分的世界市場

  • 主要發現
  • 簡介
  • 兒童
  • 成人

第 8 章依通路劃分的世界市場

  • 主要發現
  • 簡介
  • 醫院藥房
  • 零售藥局/藥局
  • 網路藥局

第 9 章依適應症劃分的全球市場

  • 主要發現
  • 簡介
  • 生長激素缺乏
  • 特納氏症
  • 特發性身材矮小
  • 普拉德-威利症候群
  • 其他

第 10 章依地區劃分的世界市場

  • 主要發現
  • 簡介
    • 2019-2032 年人類生長激素市場評估（依地區）
  • 人類生長激素市場 - 北美
    • 北美：人類生長激素市場（依類型），2019-2032 年
    • 北美：人類生長激素市場，依通路劃分，2019-2032 年
    • 北美：人類生長激素市場（依給藥途徑），2019-2032 年
    • 北美：人類生長激素市場，依年齡劃分，2019-2032 年
    • 北美：人類生長激素市場，依適應症劃分，2019-2032 年
    • 人類生長激素市場 - 美國
    • 人類生長激素市場 - 加拿大
  • 人類生長激素市場 - 歐洲
    • 歐洲：人類生長激素市場（依類型），2019-2032 年
    • 歐洲：人類生長激素市場，依通路劃分，2019-2032 年
    • 歐洲：人類生長激素市場（依給藥途徑），2019-2032 年
    • 歐洲：人類生長激素市場，依年齡劃分，2019-2032 年
    • 歐洲：人類生長激素市場，依適應症劃分，2019-2032 年
    • 人類生長激素市場 - 英國
    • 人類生長激素市場 - 法國
    • 人類生長激素市場 - 德國
    • 人類生長激素市場 - 義大利
    • 人類生長激素市場 - 西班牙
    • 人類生長激素市場 - 荷蘭
    • 人類生長激素市場 - 俄羅斯
  • 人類生長激素市場 - 亞太地區
    • 亞太地區：人類生長激素市場，依類型，2019-2032 年
    • 亞太地區：人類生長激素市場，依通路劃分，2019-2032 年
    • 亞太地區：人類生長激素市場（依給藥途徑），2019-2032 年
    • 亞太地區：人類生長激素市場，依年齡劃分，2019-2032 年
    • 亞太地區：人類生長激素市場，依指標劃分，2019-2032 年
    • 人類生長激素市場 - 中國
    • 人類生長激素市場 - 印度
    • 人類生長激素市場 - 日本
    • 人類生長激素市場 - 馬來西亞
    • 人類生長激素市場 - 印尼
    • 人類生長激素市場 - 韓國
  • 人類生長激素市場 - 中東和非洲
    • 中東和非洲：人類生長激素市場（依類型），2019-2032 年
    • 中東和非洲：人類生長激素市場，依分銷管道劃分，2019-2032 年
    • 中東和非洲：人類生長激素市場（依給藥途徑），2019-2032 年
    • 中東與非洲：人類生長激素市場，依年齡劃分，2019-2032 年
    • 中東與非洲：人類生長激素市場，依指標劃分，2019-2032 年
    • 人類生長激素市場 - 沙烏地阿拉伯
    • 人類生長激素市場 - 阿聯酋
    • 人類生長激素市場 - 以色列
    • 人類生長激素市場 - 南非
  • 人類生長激素市場 - 拉丁美洲
    • 拉丁美洲：人類生長激素市場，依類型，2019-2032 年
    • 拉丁美洲：人類生長激素市場，依通路劃分，2019-2032 年
    • 拉丁美洲：人類生長激素市場（依給藥途徑），2019-2032 年
    • 拉丁美洲：人類生長激素市場，依年齡劃分，2019-2032 年
    • 拉丁美洲：人類生長激素市場，依適應症劃分，2019-2032 年
    • 人類生長激素市場 - 墨西哥
    • 人類生長激素市場 - 巴西
    • 人類生長激素市場 - 阿根廷

第十一章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 合作/協作/合約/出版物

第十二章公司簡介

  • AnkeBio Co., Ltd
  • Ascendis Pharma
  • Eli Lilly and Company
  • Ferring Pharmaceuticals
  • Genentech, Inc（Roche）
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk
  • Pfizer Inc.
  • Sandoz International GmbH
Product Code: PM4705

The global human growth hormone market size is expected to reach USD 15.66 billion by 2032, according to a new study by Polaris Market Research. The report "Human Growth Hormone Market Share, Size, Trends, Industry Analysis Report, By Type (Long-acting, Short-acting & Intermediate-acting); By Route of Administration; By Age; By Indication; By Distribution Channel; By Region; Segment Forecast, 2023- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The scope of the Human Growth Hormone (HGH) market encompasses various dimensions that define its reach, applications, and influencing factors. The market caters to therapeutic applications of HGH, addressing medical conditions such as growth hormone deficiencies in children and adults. HGH is used to stimulate growth and development in individuals with insufficient endogenous growth hormone production.

A significant portion of the market focuses on addressing pediatric growth disorders, including conditions like short stature due to growth hormone deficiencies. HGH therapy is a common intervention to promote linear growth in children. The market extends its scope to adults with growth hormone deficiencies, where HGH is used to address conditions such as AGHD. This involves addressing health issues associated with insufficient growth hormone production in adulthood. There is a growing segment within the market that caters to anti-aging and wellness applications. HGH is sometimes used for its perceived anti-aging effects, including improvements in skin health, energy levels, and overall well-being.

Furthermore, HGH is employed in the treatment of muscle-wasting conditions and metabolic disorders. The market addresses the therapeutic use of HGH to mitigate the effects of muscle loss and improve metabolic functions in certain patient populations.

The high prevalence of growth hormone deficiency (GHD), the increasing need for treatment owing to serious risks associated with GHD, and the rising demand for medications that reduce the frequency of injections are the major factors contributing to the growth of the human growth hormone market.

Factors such as increasing cases of pituitary dysfunction and the development of more advanced technologies to enhance patient adherence to the treatment contribute to the market growth. The rising emphasis of industry players on research & development activities coupled with the strong pipeline of somatropin is expected to drive the market growth during the forecast period.

Increasing awareness related to appropriate treatment coupled with the growing initiatives by public and private organizations related to the treatment of human growth deficiency are expected to prove beneficial for the expansion of the human growth hormone market. Moreover, the increasing number of patients suffering from rare diseases across developing countries will also contribute to the market growth.

Human Growth Hormone Market Report Highlights

The long-acting segment is projected to expand at the highest CAGR during the forecast period, owing to the safety profile & effectiveness of long-acting human growth hormones.

In 2023, the growth hormone deficiency segment accounted for the largest market share, owing to the high prevalence of the disease and the rising number of new products for its treatment.

In 2023, the hospital pharmacies segment accounted for the largest market share, owing to the increasing number of patient visits to hospitals.

North America accounted for the largest revenue share in the human growth hormone market in 2023, owing to the rising cases of Turner syndrome and growth hormone deficiencies.

The market players include AnkeBio Co., Ltd, Ascendis Pharma, Novo Nordisk, Pfizer, Eli Lilly, Sandoz International, Merck, Genentech, and more.

Polaris Market Research has segmented the human growth hormone market report based on type, route of administration, age, indication, distribution channel, and region:

Human Growth Hormone, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Long-acting
  • Short-acting & Intermediate-acting

Human Growth Hormone, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oral
  • Parenteral
  • Intravenous
  • Subcutaneous
  • Intramuscular

Human Growth Hormone, Age Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pediatric
  • Adult

Human Growth Hormone, Indication Outlook (Revenue - USD Billion, 2019 - 2032)

  • Growth Hormone Deficiency
  • Turner Syndrome
  • Idiopathic Short Stature
  • Prader-Willi Syndrome
  • Others

Human Growth Hormone, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacies
  • Retail Pharmacies & Drug Stores
  • Online Pharmacies

Human Growth Hormone, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of LA
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Human Growth Hormone Market Insights

  • 4.1. Human Growth Hormone - Industry Snapshot
  • 4.2. Human Growth Hormone Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Growth Hormone Deficiency and Other Disorders
      • 4.2.1.2. Growing Number of Research & Development Activities
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Side Effects and Safety Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Human Growth Hormone Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Human Growth Hormone Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Long-acting
    • 5.3.1. Global Human Growth Hormone Market, by Long-acting, by Region, 2019-2032 (USD Billion)
  • 5.4. Short-acting & Intermediate-acting
    • 5.4.1. Global Human Growth Hormone Market, by Short-acting & Intermediate-acting, by Region, 2019-2032 (USD Billion)

6. Global Human Growth Hormone Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • 6.3. Oral
    • 6.3.1. Global Human Growth Hormone Market, by Oral, by Region, 2019-2032 (USD Billion)
  • 6.4. Parenteral
    • 6.4.1. Global Human Growth Hormone Market, by Parenteral, by Region, 2019-2032 (USD Billion)
    • 6.4.2. Intravenous
      • 6.4.2.1. Global Human Growth Hormone Market, by Intravenous, by Region, 2019-2032 (USD Billion)
    • 6.4.3. Subcutaneous
      • 6.4.3.1. Global Human Growth Hormone Market, by Subcutaneous, by Region, 2019-2032 (USD Billion)
    • 6.4.4. Intramuscular
      • 6.4.4.1. Global Human Growth Hormone Market, by Intramuscular, by Region, 2019-2032 (USD Billion)

7. Global Human Growth Hormone Market, by Age

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • 7.3. Pediatric
    • 7.3.1. Global Human Growth Hormone Market, by Pediatric, by Region, 2019-2032 (USD Billion)
  • 7.4. Adult
    • 7.4.1. Global Human Growth Hormone Market, by Adult, by Region, 2019-2032 (USD Billion)

8. Global Human Growth Hormone Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.3. Hospital Pharmacies
    • 8.3.1. Global Human Growth Hormone Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)
  • 8.4. Retail Pharmacies & Drug Stores
    • 8.4.1. Global Human Growth Hormone Market, by Retail Pharmacies & Drug Stores, by Region, 2019-2032 (USD Billion)
  • 8.5. Online Pharmacies
    • 8.5.1. Global Human Growth Hormone Market, by Online Pharmacies, by Region, 2019-2032 (USD Billion)

9. Global Human Growth Hormone Market, by Indication

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 9.3. Growth Hormone Deficiency
    • 9.3.1. Global Human Growth Hormone Market, by Growth Hormone Deficiency, by Region, 2019-2032 (USD Billion)
  • 9.4. Turner Syndrome
    • 9.4.1. Global Human Growth Hormone Market, by Turner Syndrome, by Region, 2019-2032 (USD Billion)
  • 9.5. Idiopathic Short Stature
    • 9.5.1. Global Human Growth Hormone Market, by Idiopathic Short Stature, by Region, 2019-2032 (USD Billion)
  • 9.6. Prader-Willi Syndrome
    • 9.6.1. Global Human Growth Hormone Market, by Prader-Willi Syndrome, by Region, 2019-2032 (USD Billion)
  • 9.7. Others
    • 9.7.1. Global Human Growth Hormone Market, by Others, by Region, 2019-2032 (USD Billion)

10. Global Human Growth Hormone Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Human Growth Hormone Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 10.3. Human Growth Hormone Market - North America
    • 10.3.1. North America: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.3.2. North America: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.3.3. North America: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.3.4. North America: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.3.5. North America: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.3.6. Human Growth Hormone Market - U.S.
      • 10.3.6.1. U.S.: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.3.6.2. U.S.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.3.6.3. U.S.: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.6.4. U.S.: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.3.6.5. U.S.: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.3.7. Human Growth Hormone Market - Canada
      • 10.3.7.1. Canada: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.3.7.2. Canada.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.3.7.3. Canada: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.7.4. Canada: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.3.7.5. Canada: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 10.4. Human Growth Hormone Market - Europe
    • 10.4.1. Europe: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.4.2. Europe.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.3. Europe: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.4.4. Europe: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.4.5. Europe: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.6. Human Growth Hormone Market - UK
      • 10.4.6.1. UK: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.6.2. UK.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.6.3. UK: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.6.4. UK: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.6.5. UK: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.7. Human Growth Hormone Market - France
      • 10.4.7.1. France: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.7.2. France.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.7.3. France: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.7.4. France: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.7.5. France: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.8. Human Growth Hormone Market - Germany
      • 10.4.8.1. Germany: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.8.2. Germany.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.8.3. Germany: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.8.4. Germany: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.8.5. Germany: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.9. Human Growth Hormone Market - Italy
      • 10.4.9.1. Italy: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.9.2. Italy.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.9.3. Italy: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.9.4. Italy: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.9.5. Italy: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.10. Human Growth Hormone Market - Spain
      • 10.4.10.1. Spain: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.10.2. Spain.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.10.3. Spain: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.10.4. Spain: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.10.5. Spain: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.11. Human Growth Hormone Market - Netherlands
      • 10.4.11.1. Netherlands: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.11.2. Netherlands.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.11.3. Netherlands: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.11.4. Netherlands: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.11.5. Netherlands: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.12. Human Growth Hormone Market - Russia
      • 10.4.12.1. Russia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.12.2. Russia.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.12.3. Russia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.12.4. Russia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.12.5. Russia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 10.5. Human Growth Hormone Market - Asia Pacific
    • 10.5.1. Asia Pacific: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.5.2. Asia Pacific.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.5.3. Asia Pacific: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.5.4. Asia Pacific: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.5.5. Asia Pacific: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.6. Human Growth Hormone Market - China
      • 10.5.6.1. China: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.6.2. China.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.6.3. China: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.6.4. China: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.6.5. China: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.7. Human Growth Hormone Market - India
      • 10.5.7.1. India: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.7.2. India.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.7.3. India: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.7.4. India: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.7.5. India: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.8. Human Growth Hormone Market - Japan
      • 10.5.8.1. Japan: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.8.2. Japan.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.8.3. Japan: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.8.4. Japan: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.8.5. Japan: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.9. Human Growth Hormone Market - Malaysia
      • 10.5.9.1. Malaysia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.9.2. Malaysia.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.9.3. Malaysia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.9.4. Malaysia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.9.5. Malaysia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.10. Human Growth Hormone Market - Indonesia
      • 10.5.10.1. Indonesia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.10.2. Indonesia.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.10.3. Indonesia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.10.4. Indonesia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.10.5. Indonesia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.11. Human Growth Hormone Market - South Korea
      • 10.5.11.1. South Korea: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.11.2. South Korea.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.11.3. South Korea: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.11.4. South Korea: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.11.5. South Korea: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 10.6. Human Growth Hormone Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.6.2. Middle East & Africa: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.6.3. Middle East & Africa: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.6.4. Middle East & Africa: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.6.5. Middle East & Africa: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.6.6. Human Growth Hormone Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.6.6.2. Saudi Arabia.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.6.7. Human Growth Hormone Market - UAE
      • 10.6.7.1. UAE: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.6.7.2. UAE.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.6.7.3. UAE: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.7.4. UAE: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.6.7.5. UAE: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.6.8. Human Growth Hormone Market - Israel
      • 10.6.8.1. Israel: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.6.8.2. Israel.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.6.8.3. Israel: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.8.4. Israel: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.6.8.5. Israel: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.6.9. Human Growth Hormone Market - South Africa
      • 10.6.9.1. South Africa: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.6.9.2. South Africa.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.6.9.3. South Africa: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.9.4. South Africa: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.6.9.5. South Africa: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 10.7. Human Growth Hormone Market - Latin America
    • 10.7.1. Latin America: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.7.2. Latin America.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.7.3. Latin America: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.7.4. Latin America: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.7.5. Latin America: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.7.6. Human Growth Hormone Market - Mexico
      • 10.7.6.1. Mexico: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.7.6.2. Mexico.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.7.6.3. Mexico: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.6.4. Mexico: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.7.6.5. Mexico: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.7.7. Human Growth Hormone Market - Brazil
      • 10.7.7.1. Brazil: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.7.7.2. Brazil.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.7.7.3. Brazil: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.7.4. Brazil: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.7.7.5. Brazil: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.7.8. Human Growth Hormone Market - Argentina
      • 10.7.8.1. Argentina: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.7.8.2. Argentina.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.7.8.3. Argentina: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.8.4. Argentina: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.7.8.5. Argentina: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. AnkeBio Co., Ltd
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Ascendis Pharma
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Eli Lilly and Company
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Ferring Pharmaceuticals
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Genentech, Inc (Roche)
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Merck KGaA
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Novartis AG
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Novo Nordisk
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Pfizer Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Sandoz International GmbH
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development

List of Tables

  • Table 1 Global Human Growth Hormone Market, by Type, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Human Growth Hormone Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Human Growth Hormone Market, by Age, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Human Growth Hormone Market, by Indication, by Region, 2019-2032 (USD Billion)
  • Table 5 Global Human Growth Hormone Market, by Distribution Channel, by Region, 2019-2032 (USD Billion)
  • Table 6 North America: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 7 North America: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 8 North America: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 9 North America: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 10 North America: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 U.S.: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 12 U.S.: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 13 U.S.: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 14 U.S.: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 15 U.S.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 16 Canada: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 17 Canada: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 18 Canada: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 19 Canada: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 20 Canada: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 21 Europe: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 22 Europe: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 23 Europe: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 24 Europe: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 25 Europe: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 Germany: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Germany: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 28 Germany: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 29 Germany: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 30 Germany: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 31 France: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 32 France: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 33 France: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 34 France: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 35 France: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 36 UK: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 37 UK: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 38 UK: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 39 UK: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 40 UK: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 Italy: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 42 Italy: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 43 Italy: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 44 Italy: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 45 Italy: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 46 Netherlands: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 47 Netherlands: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 48 Netherlands: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 49 Netherlands: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 50 Netherlands: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 51 Spain: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Spain: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 53 Spain: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 54 Spain: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 55 Spain: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 56 Russia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 57 Russia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 58 Russia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 59 Russia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 60 Russia: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 61 Asia Pacific: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 62 Asia Pacific: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 63 Asia Pacific: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 64 Asia Pacific: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 65 Asia Pacific: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 66 China: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 67 China: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 68 China: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 69 China: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 70 China: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 Japan: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 72 Japan: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 73 Japan: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 74 Japan: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 75 Japan: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 76 India: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 77 India: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 78 India: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 79 India: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 80 India: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 81 Indonesia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 82 Indonesia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 83 Indonesia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 84 Indonesia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 85 Indonesia: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 86 Malaysia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 87 Malaysia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 88 Malaysia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 89 Malaysia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 90 Malaysia: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 91 South Korea: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 92 South Korea: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 93 South Korea: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 94 South Korea: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 95 South Korea: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 96 Latin America: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 97 Latin America: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 98 Latin America: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 99 Latin America: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 100 Latin America: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 101 Brazil: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 102 Brazil: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 103 Brazil: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 104 Brazil: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 105 Brazil: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 106 Mexico: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 107 Mexico: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 108 Mexico: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 109 Mexico: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 110 Mexico: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 111 Argentina: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 112 Argentina: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 113 Argentina: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 114 Argentina: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 115 Argentina: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 116 Middle East & Africa: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 117 Middle East & Africa: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 118 Middle East & Africa: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 119 Middle East & Africa: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 120 Middle East & Africa: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 121 UAE: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 122 UAE: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 123 UAE: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 124 UAE: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 125 UAE: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 126 Saudi Arabia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 127 Saudi Arabia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 128 Saudi Arabia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 129 Saudi Arabia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 130 Saudi Arabia: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 131 South Africa: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 132 South Africa: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 133 South Africa: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 134 South Africa: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 135 South Africa: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 136 Israel: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 137 Israel: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 138 Israel: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 139 Israel: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 140 Israel: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Human Growth Hormone Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Human Growth Hormone Market, by Type, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Route of Administration
  • Figure 9. Global Human Growth Hormone Market, by Route of Administration, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Age
  • Figure 11. Global Human Growth Hormone Market, by Age, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Indication
  • Figure 13. Global Human Growth Hormone Market, by Indication, 2021 & 2030 (USD Billion)
  • Figure 14. Market by Distribution Channel
  • Figure 15. Global Human Growth Hormone Market, by Distribution Channel, 2021 & 2030 (USD Billion)